Adjacent segment disease is the complication people mean when they say a fusion wears out the level above it. The phrase is more precise than that fear, and the evidence is less precise than a percentage on a slide. There are two terms. Mixing them is how a routine follow-up scan becomes a second operation, or how a real new nerve problem gets dismissed as “just arthritis.”
How fusion works is in What Is Lumbar Spinal Fusion? How long any result is supposed to last is a different question, in How Long Does Lumbar Spinal Fusion Last? What should be counted as a good result is in Lumbar Fusion Outcomes This article is only the neighboring level.
Two terms that are not the same diagnosis
A review by Hilibrand and Robbins separates them. Adjacent segment degeneration means wear visible on imaging at the level next to a fusion. Adjacent segment disease means new symptoms that correspond to those changes.
Both occur after fusion. The review’s point, which is easy to lose, is that the changes may be related to natural aging, to the fusion, or to both.
That three-way cause is the whole intellectual honesty of the topic. A fused level does not bend, so the levels that still bend share motion they did not share in the same way before. That is a mechanical story.
Discs also dry out in people who never had surgery. Brinjikji and colleagues found disc degeneration in a large share of asymptomatic adults, rising from about 37 percent at age 20 to about 96 percent at age 80. A worn disc above a fusion in a 70-year-old is not automatically the fusion’s fault.
It is also not automatically innocent. The symptom match is what sorts those possibilities.
Comparison
Wear on a scan, new symptoms, and another operation
These three get collapsed into one label. Imaging wear is common with age. New symptoms have to match the next level. Another operation is a further, separate event, and studies do not agree on one rate.
Imaging wear
A disc, joint, or narrow canal at the next level on a scan. Common with age. This is degeneration.
New symptoms
Pain or nerve findings that were not the old problem, lining up with that next level. This is disease, if the match holds.
Another operation
What some people with disease eventually have. Studies do not agree on one rate, so this column has no honest percentage.
A mark in the first column does not fill in the second or the third.
What a new pain still has to prove
The scar is a distractor. Pain years later can be the next level, the fused level if it did not solidify, the hip, or the problem you had on day one that never left. AAOS describes fusion recovery and the possibility of later issues in general patient guidance.
It does not give you a test you can do in the kitchen to name the adjacent segment. The test is a history that is actually new, an exam, and images read against that exam.
If the images are worse and you feel the same as last year, you have learned that pictures move. If you feel worse and the images are unchanged, you have learned that the picture is not the symptom. Either result is useful.
Neither one is “the fusion failed” by default. Failure of the bone to unite is a different diagnosis from disease at the next level. They can coexist. They should not share a sentence until someone has looked for both.
| What the report says | What it describes | What it does not decide |
|---|---|---|
| Degeneration at the adjacent level | Wear on the image | That you have new disease, or that you need more surgery |
| Narrowing at the adjacent level | Less room for a nerve on that slice | That this narrowing explains today's pain. The old level and the hip are still in play |
| No mention of the next level | This scan did not feature it | That a new symptom has no spinal source. The exam still matters |
What this should change in the original decision
If you are not yet fused, adjacent-level risk is a reason to be sure the fusion is indicated, not a reason to memorize a percentage nobody can individualize. Hilibrand and Robbins did not produce a personal forecast, and later papers have not converged on one number this article is willing to pretend is yours. Study limits should stay attached to the populations those studies enrolled. A consult that says “the next level always goes” is smoother than the review, and less true.
If you are choosing between fusion and a motion-preserving implant, the mechanical hope of the implant is that the treated level still moves, which might load the neighbors differently. The FDA summary of the TOPS System defines a narrow group. Being worried about the next level does not place you in that group.
The comparison explains the structural difference. It is not a guarantee about neighboring discs.
If you are already fused and a new symptom shows up, take the new symptom seriously and the old scan’s adjectives lightly. Write down what is new. That note is how disease stays distinct from a line on a film, which is the only distinction that keeps this complication from swallowing every ache you will ever have.
What surgeons can and cannot promise beforehand
They can tell you a fused level does not bend, so motion is shared by the levels that remain. They can tell you discs age anyway, and show you that asymptomatic adults accumulate degeneration decade by decade. They cannot tell you your personal chance of a second fusion at five or ten years without pretending the studies agree.
If a consent quotes a tight percentage, ask for the paper and the definition: imaging only, or symptoms, or reoperation. Those three denominators produce three “rates,” and only the last one is an operation. Hilibrand and Robbins are useful because they refuse the collapse.
A newer paper that picks one denominator is useful too, if it is named. An unnamed rate is not.
Prevention advice should stay equally modest. Keeping the fusion to the fewest levels the problem requires is a structural way to leave more motion in the spine. It is not a proven vaccine against adjacent disease.
Core exercise after you are healed does not unfuse the level and has not been shown, in anything this article can cite, to zero the risk. It may still be good for the rest of you. Do not let a wellness plan be sold as insurance against the next disc.
If you already have the label
Live by the symptom. A scan that says adjacent degeneration, attached to a stable walk, can be filed. A new walking limit or a new nerve pattern gets an exam, the way any new stenosis symptom would, whether or not a fusion sits below it.
The workup is not “you knew this would happen.” The workup is whether this level, now, matches this leg. Surgery at the next level, if it is offered, needs its own indication. It is not a maintenance plan triggered by the calendar.
Bring the original operative note so the next person knows how many levels are already solid and which approach was used. Scar and hardware change the technical options. They do not change the logic.
Disease is symptoms plus a matching level. Everything else is a picture of an older spine, which you were going to have with or without the first operation, on a schedule nobody can print for you today.
Families hear “adjacent segment” and picture a cascade, each level falling in turn. That picture is more frightening than the review, and it is not what follow-up looks like for many people. One neighboring level can become symptomatic.
Several can look older on a scan and never announce themselves. A second operation, when it happens, is a new consent, not the second payment on a plan you already bought. Ask, if it is offered, whether this is disease at the next level or a nonunion at the first, because the operations differ.
You can also ask what will be watched and what will be ignored. A stable scan and a stable walk can be ignored on purpose. That is not neglect.
It is the distinction between degeneration and disease, practiced at home. Write the walk down twice a year if you want a record. You do not need a new MRI to complete the ritual.
The MRI comes when the walk changes or a nerve finding appears. Until then, the fusion’s neighbor is allowed to be an ordinary older disc, which is what most older discs are, fused level or not.
If you are still deciding, put this risk in the same sentence as the indication. “We are fusing one level because it moves, and the next level might later become symptomatic for reasons that include aging and the fusion, at a rate I cannot honestly personalize.” That sentence is complete.
“Don’t fuse, the next level always dies” is not. “Fusion is permanent and nothing nearby changes” is not either. Hilibrand and Robbins left the cause shared.
You can leave it shared in the consent and still make a decision. Decisions under uncertainty are what this operation requires. A fake percentage would feel calmer and would be less true.
The clinical evidence page is where to park any paper a clinic hands you that does quote a rate. Check the denominator before you let it frighten you or reassure you. Imaging rates are the highest and the least meaningful.
Reoperation rates are lower and are the ones that change a life. Symptom rates sit in between and depend on how carefully someone matched the pain to the level. If the handout does not say which of the three it is, it is not yet about adjacent segment disease.
It is about a word. You have already learned what the word must contain. Do not give that lesson back at the door.
The lesson is small enough to remember: a picture is not a symptom, a symptom needs a matching level, and a second operation needs its own reason. Aging will keep producing pictures. It does not get to schedule your next surgery by itself.
You schedule the next conversation when a symptom changes, and you schedule nothing when the only thing that changed is another year on a scan. That is the whole prevention available to you after the fact, and it is more accurate than a fear that every fused spine is a countdown. Share that distinction with the person who worries with you.
They are often more frightened by the phrase than you are, and they will push for scans you do not need or for a second fusion you have not indicated. The phrase is manageable once it is split into a picture, a symptom, and an operation. Leave it split.
A split phrase is something you can consent to. A countdown is not.
Frequently asked questions
Does every fusion cause the next level to wear out?
No. Neighboring levels can look more worn over time, and some of that would have happened without a fusion because discs age. A 2004 review treats adjacent segment degeneration and disease as consequences that may be related to the fusion, to natural history, or to both. It does not give you a personal percentage, and this article will not invent one. A stiff segment does change how motion is shared. That mechanical idea is plausible and is not the same as proof that your next level is scheduled to fail. Many people never need a second fusion.
If my MRI shows degeneration above the fusion, do I have the disease?
Not from the picture alone. Degeneration is the imaging word. Disease is the symptom word, used when new pain or nerve symptoms correspond to that level. A worn disc on a scan of a person who is walking well is a finding. It is the same trap as any other spine image: common changes in people with and without pain. Treat the new symptom, if there is one. Do not treat the adjective. Ask whether the new pain matches the new level, or whether it is the old problem, the hip, or something else.
How do I know a new pain is the adjacent level?
You do not know from the location of the scar. A clinician compares the new story, the exam, and images of the neighboring level. Pain that starts years later and behaves like a fresh nerve compression deserves that workup. Pain that never left after the first operation may be the original level, a nonunion, or a problem that was never the fusion's target. Time since surgery is a clue, not a diagnosis. Bring the old notes so 'new' is actually new.
Should I avoid fusion because of this risk?
You should hear the risk and then put it next to the problem fusion is being asked to solve. If the level does not need to be fused, the adjacent-level question is one more reason not to add a fusion for completeness. If the level moves, or decompression alone will not hold, the adjacent-level risk is a real downside of a real indication, not a reason to pretend the indication vanished. No study in this article gives a clean 'percent chance your next level will need surgery' that applies to you. Uncertainty is part of the consent.
Does a motion-preserving device avoid adjacent segment disease?
It is designed to leave some motion at the treated level, which is a different mechanical idea from a fusion. That design aim is not the same as proof that neighboring levels are protected in you. Any such claim has to come from comparative evidence in a defined group, not from the brochure. The FDA indication for one such device is narrow. Most people considering fusion are outside it. Do not choose, or refuse, a fusion because a device might spare the next level unless you are actually in the group that was studied.
Key takeaways
- Degeneration is a scan finding at the next level. Disease means symptoms that match it. They are not interchangeable.
- Aging and the fusion can both contribute. Studies have not handed every patient a single risk number.
- A worn neighbor on MRI, without new symptoms, is not an automatic second operation.
- The risk belongs in the original decision. It does not, by itself, ban a fusion that has a clear job.
References
- Hilibrand AS, Robbins M. Adjacent segment degeneration and adjacent segment disease: the consequences of spinal fusion?. The Spine Journal. 2004;4(6 Suppl):190S-194S. 2004.
- Spinal Fusion. OrthoInfo, American Academy of Orthopaedic Surgeons.
- Brinjikji W, Luetmer PH, Comstock B, et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. American Journal of Neuroradiology. 2015;36(4):811-816. 2015.
- TOPS System – P220002. U.S. Food and Drug Administration. 2023.
Review the clinical evidence
See what the FDA reviewed for the TOPS System, which patients were studied, how success was defined, and where the evidence has limits.



